Finally, IFNα and IL6 served only as early immune responses directed against SARS-CoV-2 (Figures 7A, B and Supplementary Figure 9) but not the severity of the disease in both active and convalescent COVID-19 phases. The gene discussed is IFNA1; the disease is COVID-19.